95% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
Yunia Mayanja1,2*
Ivy Kayesu1
Onesmus Kamacooko3
Jane Frances Lunkuse1
Vincent Muturi-Kioi4
Matt Price5,6
Kyriaki Kosidou2,7Anna Mia Ekström2,8,9- 1Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine (MRC/UVRI & LSHTM) Uganda Research Unit, Entebbe, Uganda
- 2Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden
- 3Child Health and Development Centre, School of Medicine, Makerere University, Kampala, Uganda
- 4IAVI, Nairobi, Kenya
- 54IAVI, New York, NY, United States
- 6Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, United States
- 7Centre for Epidemiology and Community Medicine, Region Stockholm, Stockholm, Sweden
- 8Department of Infectious Diseases/Venhälsan, Södersjukhuset, Stockholm, Sweden
- 9Department of Clinical Science and Education, Södersjukhuset, Stockholm, Sweden
A Corrigendum on
Preference for novel biomedical HIV pre-exposure prophylaxis methods among adolescent girls and young women in Kampala, Uganda: a mixed methods study
by Mayanja, Y., Kayesu, I., Kamacooko, O., Lunkuse, J. F., Muturi-Kioi, V., Price, M., Kosidou, K., and Ekström, A. M. (2024). Front. Public Health. 12:1369256. doi: 10.3389/fpubh.2024.1369256
In the published article, there was an error in the Funding statement. The project code for the EDCTP funder was erroneously written as “3120” instead of “3102” and we listed project activities funded rather than use the generic funder statement.
The original text is, “The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was funded by IAVI and made possible by the support of many donors including United States Agency for International Development (USAID). The full list of IAVI donors is available at http://www.iavi.org. IAVI also sponsored the study and therefore contributed to the study design, monitored the study and, representatives reviewed and approved all versions of the manuscript. The East Africa Consortium for Clinical Research/736 EACCR3 (CSA2020NoE-3120) under the European and Developing Countries Clinical Trials 737 Partnership (EDCTP2) provided funding for travel and supervision of this work as part of doctoral 738 studies at Karolinska institute”.
The correct Funding statement appears below.
Funding
The author(s) declare that financial support was received for the research and/or publication of this article. This work was funded by IAVI and made possible by the support of many donors including United States Agency for International Development (USAID). The full list of IAVI donors is available at http://www.iavi.org. IAVI also sponsored the study and therefore contributed to the study design, monitored the study and, representatives reviewed and approved all versions of the manuscript. This project is part of the EDCTP2 program supported by the European Union (CSA2020NoE-3102). The views and opinions of authors expressed herein do not necessarily state or reflect those of EDCTP.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: pre-exposure prophylaxis, biomedical HIV prevention, preference, adolescent girls and young women, Uganda, Eastern and Southern Africa
Citation: Mayanja Y, Kayesu I, Kamacooko O, Lunkuse JF, Muturi-Kioi V, Price M, Kosidou K and Ekström AM (2025) Corrigendum: Preference for novel biomedical HIV pre-exposure prophylaxis methods among adolescent girls and young women in Kampala, Uganda: a mixed methods study. Front. Public Health 13:1597921. doi: 10.3389/fpubh.2025.1597921
Received: 21 March 2025; Accepted: 24 March 2025;
Published: 02 April 2025.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2025 Mayanja, Kayesu, Kamacooko, Lunkuse, Muturi-Kioi, Price, Kosidou and Ekström. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Yunia Mayanja, eXVuaWEubWF5YW5qYUBtcmN1Z2FuZGEub3Jn; eXVuaWEubWF5YW5qYUBraS5zZQ==